Small caps round-up: Acta, GW Pharma, Pure Wafer

Clean energy products company Acta has announced the shipment of the first fully integrated fuel cell telecom back-up power system, incorporating Acta's onboard hydrogen generation for automatic fuel replenishment. The completed system has been shipped to Acta's Australian marketing and distribution partner and is to be put on field trial with a major Australian telecoms company in the near future. The company said that on the basis of a five-year total cost of ownership, the system is cheaper than diesel or battery-based alternatives, while incurring none of their environmental disadvantages.

By MoneyWeek

published 1 October 2012

in Features

GW Pharmaceuticals, the developer of cannabis-based medicinal products, has appointed Christopher Tovey to the newly created position of Chief Operating Officer. Tovey, 47, has been in the pharmaceutical industry for more than 25 years and was most recently the Vice President of Global Marketing Operations at UCB Pharmaceuticals, where he was responsible for worldwide marketing activities on a portfolio of UCB products generating over €2.0bn in annual sales.

Pure Wafer, which provides silicon wafer reclaim services for semiconductor manufacturers globally, posted a pre-tax loss of $0.7m for the year ended June 30th, compared to $5.1m the previous year, on turnover of $35.8m (2011: $29.7m). BAsic losses per share for the year totalled 0.2 cents, down from a loss per share of 3.6 cents the previous year. The company attributed the improved results to increased sales volumes and steady selling prices.